Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for CERS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 50.61%
March 31, 2026 51.98%
December 31, 2025 51.51%
September 30, 2025 53.40%
June 30, 2025 55.25%
March 31, 2025 58.80%
December 31, 2024 53.90%
September 30, 2024 56.93%
June 30, 2024 54.72%
March 31, 2024 55.45%
December 31, 2023 54.12%
September 30, 2023 54.85%
June 30, 2023 54.92%
March 31, 2023 55.81%
December 31, 2022 55.72%
September 30, 2022 55.37%
June 30, 2022 51.91%
March 31, 2022 51.73%
December 31, 2021 51.15%
September 30, 2021 51.34%
June 30, 2021 51.33%
March 31, 2021 52.54%
December 31, 2020 56.81%
September 30, 2020 53.60%
June 30, 2020 54.87%
Date Value
March 31, 2020 55.30%
December 31, 2019 62.57%
September 30, 2019 57.92%
June 30, 2019 55.46%
March 31, 2019 51.83%
December 31, 2018 58.29%
September 30, 2018 57.87%
June 30, 2018 60.34%
March 31, 2018 56.93%
December 31, 2017 48.54%
September 30, 2017 55.64%
June 30, 2017 57.16%
March 31, 2017 50.64%
December 31, 2016 52.69%
September 30, 2016 47.29%
June 30, 2016 45.66%
March 31, 2016 43.49%
December 31, 2015 35.66%
September 30, 2015 30.27%
June 30, 2015 19.83%
March 31, 2015 38.07%
December 31, 2014 30.73%
September 30, 2014 44.61%
June 30, 2014 44.16%
March 31, 2014 46.52%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
DexCom, Inc. 63.44%
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%

Gross Profit Margin (Quarterly) Related Metrics